Integrating metabolomics, bionics, and culturomics to study probiotics-driven drug metabolism.
Integrating metabolomics, bionics, and culturomics to study probiotics-driven drug metabolism.
复制标题
DOI:
10.3389/fphar.2023.1047863
复制
发表时间:
2023
影响因子:
5.6
通讯作者:
Chen, Yongfu
中科院分区:
文献类型:
--
作者:
Li, Bohai;Kwok, Lai-Yu;Wang, Dandan;Li, Lu;Guo, Shuai;Chen, Yongfu
Many drugs have been shown to be metabolized by the human gut microbiome, but probiotic-driven drug-metabolizing capacity is rarely explored. Here, we developed an integrated metabolomics, culturomics, and bionics framework for systematically studying probiotics-driven drug metabolism. We discovered that 75% (27/36 of the assayed drugs) were metabolized by five selected probiotics, and drugs containing nitro or azo groups were more readily metabolized. As proof-of-principle experiments, we showed that Lacticaseibacillus casei Zhang (LCZ) could metabolize racecadotril to its active products, S-acetylthiorphan and thiorphan, in monoculture, in a near-real simulated human digestion system, and in an ex vivo fecal co-culture system. However, a personalized effect was observed in the racecadotril-metabolizing activity of L. casei Zhang, depending on the individual’s host gut microbiome composition. Based on data generated by our workflow, we proposed a possible mechanism of interactions among L. casei Zhang, racecadotril, and host gut microbiome, providing practical guidance for probiotic-drug co-treatment and novel insights into precision probiotics.
登录
查看更多内容
影响因子:
4.2
作者:
Mathipa, Moloko Gloria;Thantsha, Mapitsi Silvester
通讯作者:
Thantsha, Mapitsi Silvester
影响因子:
4.6
作者:
Padayachee, Tiara;Nzuza, Nomfundo;Syed, Khajamohiddin
通讯作者:
Syed, Khajamohiddin
影响因子:
11
作者:
Lawson, Melissa A. E.;O'Neill, Ian J.;Hall, Lindsay J.
通讯作者:
Hall, Lindsay J.
影响因子:
56.9
作者:
Falony, Gwen;Joossens, Marie;Raes, Jeroen
通讯作者:
Raes, Jeroen
影响因子:
5.3
作者:
Li, Kangning;Wang, Shaojing;Zhang, Wenyi
通讯作者:
Zhang, Wenyi